Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage

Current — Somerset Therapeutics, LLC

The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Somerset Therapeutics, LLC with status Current. The shortage was first posted on Apr 10, 2020.

Shortage details

Status
Current
Company
Somerset Therapeutics, LLC
Package NDC
70069-759-04
Dosage Form
Injection
Presentation
Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-759-04)
Initial Posting
Apr 10, 2020

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.